Enzalutamide blows Bicalutamide out of the water in STRIVE trial at AUA15

At AUA 2015 in New Orleans, Dr Celestia Higano (Seattle) presented the results of the STRIVE clinical trial.

May 17, 2015

Impact of TERRAIN trial on European Prostate Cancer treatment landscape #EAU15

The results of the TERRAIN prostate cancer clinical trial data were presented at the 2015 European Association of Urology (EAU) Congress in Madrid today.

March 24, 2015

AUA 2015 Update on bladder cancer

Update on checkpoint inhibitors in urothelial bladder cancer from AUA 2015 and what's in store for new developments with this disease.

May 15, 2015

Enzalutamide beats bicalutamide in advanced prostate cancer

The Phase 2 TERRAIN trial met its primary endpoint (PFS) with enzalutamide beating out bicalutamide in castrate resistant prostate cancer. What next?

January 22, 2015

Insights on the enzalutamide PREVAIL data pre-chemotherapy in advanced prostate cancer

Medivation and Astellas provided an update at AUA 2014 on the Xtandi PREVAIL data with a breakdown for visceral and non-visceral disease.

May 19, 2014

AUA 2014 – New targets in prostate cancer

New targets are emerging in advanced prostate cancer that may help improve outcomes and overcome adaptive resistance

May 18, 2014